Category: Biotechnology
Biotechnology market research reports by GlobalData
-
e-Therapeutics Plc - Strategic SWOT Analysis Review
e-Therapeutics Plc - Strategic SWOT Analysis Review provides - a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s ... Read More
-
Analytik Jena GmbH+Co. KG - Strategic SWOT Analysis Review
Analytik Jena GmbH+Co. KG - Strategic SWOT Analysis Review provides - a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product ... Read More
-
AIM ImmunoTech Inc (AIM) - Financial and Strategic SWOT Analysis Review
AIM ImmunoTech Inc (AIM) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse ... Read More
-
Startup Series - Unicorn Quest: Innovators in Medical and Pharma
Startup Series - Unicorn Quest: Innovators in Medical and Pharma Summary GlobalData's Startup Series report, Unicorn Quest - Innovators in Medical and Pharma, highlights startups poised to become unicorns in the medical and pharma sectors. It explores how advancements such as AI-driven diagnostics, ... Read More
-
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis Summary This report covers the 8 major markets and provides an Excel-based forecast model for the Alzheimer’s Disease market through 2033. GlobalData estimates that the value of the Alzheimer’s Disease (AD) market in the 8MM in 2023 ... Read More
-
Strategic Intelligence: The State of the Biopharmaceutical Industry 2025
Strategic Intelligence: The State of the Biopharmaceutical Industry 2025 Summary A range of macroeconomic and geopolitical factors, along with the rise of emerging technologies, such as AI and automation, are shaping the current business landscape. While adoption of technologies can offer potential ... Read More
-
3-D Matrix Ltd (7777) - Financial and Strategic SWOT Analysis Review
3-D Matrix Ltd (7777) - Financial and Strategic SWOT Analysis Review 3-D Matrix Ltd (7777) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear ... Read More
-
Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review
Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalDa ... Read More
-
Innovation Insights: Anti-sense Oligonucleotides
Innovation Insights: Anti-sense Oligonucleotides Summary Antisense oligonucleotides (ASOs) are short, synthetic strands of DNA or RNA designed to bind to specific mRNA sequences, thereby modulating gene expression. They work through mechanisms such as RNase H-mediated degradation, steric blocking, a ... Read More
-
Innovation Insights: Engineered Multispecific antibodies
Innovation Insights: Engineered Multispecific antibodies Summary Engineered multispecific antibodies (MsAbs) are innovative therapeutic molecules designed to bind simultaneously to multiple epitopes on the same or different targets. This capability allows them to address complex diseases more effect ... Read More
-
Innovation Insights: B-cell Depletion
Innovation Insights: B-cell Depletion Summary B cell depletion is a therapeutic strategy aimed at reducing the number of B lymphocytes, which play a crucial role in autoimmune diseases and certain cancers. This approach is primarily used to treat conditions like rheumatoid arthritis, multiple sclero ... Read More
-
Cell & Gene Therapies in Gastrointestinal Disorders: Therapeutic Analysis
Cell & Gene Therapies in Gastrointestinal Disorders: Therapeutic Analysis Summary Currently, there are only two cell and gene therapies (CGTs) on the market across all gastroenterology (GI) indications. Anterogen’s Cupistem, indicated for the treatment of anal fistula in adult patients, was the firs ... Read More
-
Percheron Therapeutics Ltd (PER) - Financial and Strategic SWOT Analysis Review
Percheron Therapeutics Ltd (PER) - Financial and Strategic SWOT Analysis Review Percheron Therapeutics Ltd (PER) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData t ... Read More
-
Stealth BioTherapeutics Inc. - Strategic SWOT Analysis Review
Stealth BioTherapeutics Inc. - Strategic SWOT Analysis Review Stealth BioTherapeutics Inc. - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information ... Read More
-
Aceragen Inc - Strategic SWOT Analysis Review
Aceragen Inc - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service ... Read More
-
ZiP Diagnostics Pty Ltd - Product Pipeline Analysis, 2024 Update
Summary ZiP Diagnostics Pty Ltd (ZiP Diagnostics) is a biotech company that develops solutions for the diagnosis of infectious diseases. The company's products include animal health products, assay customisation products, cleaning and decontamination products, environmental testing products, human h ... Read More
-
Sera Prognostics Inc (SERA) - Product Pipeline Analysis, 2024 Update
Summary Sera Prognostics Inc (Sera Prognostics) is a biotechnology firm, that specializes in providing diagnostic tests for predicting the risk of pregnancy complications such as premature birth and preeclampsia. It offers PreTRM, a proteomic predictor of premature birth risk for clinicians, mothers ... Read More
-
Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review
Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak ... Read More
-
Dominari Holdings Inc (DOMH) - Financial and Strategic SWOT Analysis Review
Dominari Holdings Inc (DOMH) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn ... Read More
-
Drug Development Trends in China
Drug Development Trends in China Summary China has emerged as a critical player in global drug development, driven by robust innovation. The pharmaceutical industry in China has seen a surge in drug development activities in recent years, with an increasing focus on innovative therapies such as CAR- ... Read More
-
Immunocore Holdings Plc (IMCR) - Financial and Strategic SWOT Analysis Review
Immunocore Holdings Plc (IMCR) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More
-
Cell and Gene Therapies - Current and Future Landscape
Cell and Gene Therapies - Current and Future Landscape Summary The global CGT market is expected to reach sales of $76.03 billion by 2030, at a CAGR of 44%, driven by gene-modified cell therapies and gene therapies. The development of CGTs in oncology is still focused on blood cancers, but there are ... Read More
-
NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review
NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str ... Read More
-
Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review
Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we ... Read More
-
genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review
genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and ... Read More
Research Assistance
